HMG COA REDUCTASE INHIBITOR-INDUCED MYOTOXICITY - PRAVASTATIN AND LOVASTATIN INHIBIT THE GERANYLGERANYLATION OF LOW-MOLECULAR-WEIGHT PROTEINS IN NEONATAL RAT MUSCLE-CELL CULTURE
Op. Flint et al., HMG COA REDUCTASE INHIBITOR-INDUCED MYOTOXICITY - PRAVASTATIN AND LOVASTATIN INHIBIT THE GERANYLGERANYLATION OF LOW-MOLECULAR-WEIGHT PROTEINS IN NEONATAL RAT MUSCLE-CELL CULTURE, Toxicology and applied pharmacology, 145(1), 1997, pp. 99-110
In previous studies, inhibition of cholesterol synthesis by HMG CoA re
ductase inhibitors (HMGRI) was associated with myotoxicity in cultures
of neonatal rat skeletal myotubes, and rhabdomyolysis in rats, rabbit
s, and humans in vivo. In vitro myotoxicity was directly related to HM
GRI-induced depletion of mevalonate, farnesol, and geranylgeraniol, si
nce supplementation with these intermediate metabolites abrogated the
toxicity. Both farnesol and geranylgeraniol are required for the postt
ranslational modification, or isoprenylation, of essential regulatory
proteins in mammalian cells. The objective of the present study was to
measure changes in protein isoprenylation in cultured neonatal rat sk
eletal muscle cells exposed for 24 hr to increasing concentrations of
pravastatin or lovastatin. Proteins were labeled with [H-3]mevalonate,
[H-3]farnesyl pyrophosphate (FPP), or [H-3]geranylgeranyl pyrophospha
te (GGPP), and then separated by SDS-PAGE and quantitated by scintilla
tion counting and densitometry of autoradiographs. Mevalonate and FPP
labeling of the majority of proteins increased in a concentration-depe
ndent manner, even at concentrations greater than 2 mu M lovastatin an
d 25 mu M pravastatin that completely inhibited cholesterol synthesis.
In contrast, mevalonate and FPP labeling of three protein bands with
molecular weights of 26.6, 27.7, and 28.9 kDa was markedly inhibited a
t concentrations higher than 1 mu M lovastatin and 400 iud pravastatin
, which inhibited protein synthesis and disrupted myotube morphology a
fter longer exposures in a previous study. In contrast, these proteins
were equally well labeled by GGPP at al HMGRI concentrations tested,
suggesting that isoprenylation of the 26.9-, 27.8-, and 28.9-kDa prote
ins requires geranylgeraniol. The results of this study indicate that
HMGRI-induced myotoxicity is most likely related to reduced posttransl
ational modification of specific regulatory proteins by geranylgeranio
l. (C) 1997 Academic Press.